chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Prior to vaccine took 2 acetominophen.  Upon injection had sensation of an angry bee sting that subsided in a few minutes. Left shoulder, neck & arm very sore, iced injection site within 1 hour of receiving.  Early evening, didn't feel well-- upset stomach, loss of appetite, head ache, lethargic.  Ended up sleeping abnormal amount over next 3 days with aches in joints, specifically in hands & knees.
Information has been received from a nurse practitioner concerning multiple patients who were vaccinated with GARDASIL. Some of the patients experienced injection-site pain especially after the 2nd dose. Unspecified medical attention was sought. Subsequently, the patients recovered from injection-site pain. No other information was provided. This is one of several reports received from the same source. Additional information has been requested.
Localized erythema, warmth to touch, tenderness at injection site. Pt. reported fever developed the day after vaccine was administered.  Pt. was seen at clinic for treatment on 07/17/09 with temp. of 98.7 F.  She was prescrived Augmentin, Zyrtec and instructed to apply warm compresses.
Follow-up information, upgrading this case to serious status, has been received that pertains to event details, patient demographics, medical history and product details. Information regarding PREVNAR was received from a healthcare professional regarding a female patient who experienced pertussis/para pertussis. The patient received the first dose on 25-May-2008. The patient also received the second dose of Poliomyelitis Vaccine inactivated (manufacturer unknown) on 25-May-2008. On 28-May-2008, the patient was hospitalized for 2 days with clinical pertussis/para pertussis. The patient is still coughing but slowly improving. The reporter commented that in his opinion, the event was not related to PREVNAR. No additional information was available at the time of this report.
Not able to leave bed for 3 days after vaccine and very fatigued. Felt mostly back to normal the weekend of 4/3/21 then fatigue returned around 4/6/21 accompanied by generalized weakness, tremor or upper and lower extremities and increased shortness of breathe. Then became dependent on someone else to get up, stand. Was unable to walk due to severity of tremor in upper and lower extremities. Continues to have tremor in rehab facility where he is residing at this time after hospitalization.
Severe swelling in left armpit for multiple days accompanied by aching and soreness on arm, in armpit and upper torso.
Patient developed blistery, erythematous rash to right T12 dermatome.  Patient reports slight burning sensation on right arm and right thigh region.  Patient denies pain.     Adverse effect is reported in 1-6% of patients according to package insert.
Pt filled a VAR and said he had previously had a flu shot. Gave pt flu shot, and within about a minute pt. said  he was light headed. I told him to remain seated and went to the pharmacy to grab epi just in case. came back 30 sec after and pt was on chair with body flexed, face red , and didn't respond when I talked to him. Also his respiration sounded wheezy, so I gave him an epi-pen. Pt was alert immediately. called 911 - EMS arrived and did vitals and everything was OK. Pt went home w/wife. Pt came into pharm 4 hours later and was OK. Called pt the next evening an he was good.
pt recv vax 23SEP96 & 23SEP96 pt exp a low grade fever, achiness & chills;No further details were provided;
Patient was administered .5ml doses instead of .25 dose, bottle says .25ml, actual vial contained .5ml
Happened on June 30, 2010, pre-employment process. On 6/30/10, received 2 vaccines (MMR and Hepatitis B). On 7/1 noted "red, itchy bumps" were forming on all extremities and swelling (L) arm. Saw doctor and received topical BENADRYL and PO Prednisone; bumps and swelling mostly resolved 7/7/10.
Diarrhea, vomiting and fatigue lessened since shot but still Happening daily no fever on day 6 of first shot
Patient developed a swollen arm approximately 4 inches around vaccine site (approximately 10 minutes after administration). Ice pack administered 15 minutes after administration. It developed into rash up neck and face. Patient stated her mouth was tingling and she felt "funny." I offered Benadryl, which she stated she was allergic. Then stated we needed to administer an EpiPen and would also be required to call 911. Patient consented to EpiPen and ambulance. I called 911 and EpiPen was administered by myself at 11: 20. Ambulance arrived at 11:23.
"Faint for 5 minutes 6 hs after the shot"; "Some dizzy and light headed'; Arm Sore; A spontaneous report  was received from a consumer concerning a 32-year-old female patient who received Moderna (mRNA-1273) vaccine and Fainted/Syncope and was dizzy and light headed/dizziness, and experienced Arm sore/ Vaccination site pain.  The patient's medical history was not provided. No Relevant concomitant medications were reported.  On 15 Mar 2021, prior to the onset of symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number: 002B21A) for prophylaxis of COVID-19 infection.   On 15 Mar 2021, the patient fainted for 5 minutes, about 6 to 8 hours post vaccine administration. The patient was dizzy and lightheaded and experienced arm soreness. The event, fainted for 5 minutes, about 6 to 8 hours post vaccine administration was considered medically significant.  No Treatment information were provided.  Action taken with mRNA-1273 in response to the event(s) was unknown.  On 15 Mar 2021, the outcome of the event, fainted for 5 minutes, about 6 to 8 hours post vaccine administration was considered resolved   The outcome of the events,  was dizzy and  lightheaded, and experienced Arm sore were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
With Both Vaccines I experienced, Cold chills, Fever, Fatigue, body Aches, stomach aches, Nausea,( Vomiting and Diarrhea with 1st only)
Administered a dose of the Moderna COVID-19 vaccine after the 30 day beyond use date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered a dose of the Moderna COVID-19 vaccine after the 30 day beyond use date) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002M21A) for COVID-19 vaccination.     No Medical History information was reported.    In May 2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In May 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered a dose of the Moderna COVID-19 vaccine after the 30 day beyond use date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered a dose of the Moderna COVID-19 vaccine after the 30 day beyond use date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported by reporter.  Patient took 2nd booster.  No treatment medication was reported by reporter.
Pt presented with c/o one day scalp itching then woke up this morning with hives all over her body. Pt stated she felt her lips and face were slightly more swollen and she had a lot of itching and felt swollen behind her ears. Did not report any fever, abd pain, n/v., difficulty breathing, or SOB.
This spontaneous consumer report (initial receipt 08-Oct-2012) concerns a 52 year old female patient with a medical history of allergy to sulfur drugs. On 06-Oct-2012, the patient received 0.5 ml of AFLURIA (batch no. unspecified) via intramuscular injection. Several hours later the patient developed soreness and tenderness at the injection site. It hurt to lift her arm. She also developed fever, headache, dizziness and fatigue. The adverse effects of headache and fatigue ebbs and wanes in severity. The patient was still experiencing symptoms on 08-Oct-2012. The patient was treated with paracetamol and ibuprofen. The event outcome was not yet recovered.
Patient developed swelling of throat and uvula about 2-3days after the first dose was administered. The first dose was administered 8/14/21 and the uvula swelling occurred in the morning of 8/17/21 and lasted approximately 24hrs. Patient did not report going to the hospital for this incident.
A friend and I who planned a trip chose to have flu shots after many previous ones. We did on 10/10/03. There were no unexpected symptoms till about 9:15 following 1st service about 9:15 10/12/03. I'd been up since 5:00, read paper, sang at 1st service and then began feeling feel. Underlined symptoms on sheet given us were all experienced ending in a 911 call and rest at hospital till I came out of it all about 5:30 PM and was sent home Tues to get ready for (unreadable).
Low grade fever, chills, sore all over, lethargy; resolved by the next morning.
MIGRAINE HEADACHES AND PAIN IN MY BACK AND WEAKNESS  11/10/09 Medical records received for: Date range 10/23-11//02. Final DX as listed below:  DOS 10/23/09 Final DX: Viral syndrome, adverse effect other, nausea, anxiety DOS 10/30/09. Final DX: Anxiety, headache, myalgia, malaise and fatigue, anxiety, viral syndrome (NOS), probable.  DOS 11/2/09 Final DX: Post vaccination somatic complaints, hypokalemia, liver anomaly (unspecified). Persistent HA, Insomnia.  CT neg. Increased LFTs  4 days s/p vaccine. C/O back ache and head pain. Head sensations. ill after flu vaccine.  Continued. Multiple ED visits.  chills decreased appetite anxiety, insomnia. X10 days.  Migraine like HA and flu-like sx. Abn LFTs.  11/10/2009 ED record for 11/2/2009, patient with c/o's headaches, myalgias, poor sleep. Tx Dx studies and labs. DC DX's, headache, malaise/fatigue, myalgias, anxiety and viral syndrome. DC meds: Ativan, Vicodin and Naprosyn   11/18/2009 ED records for 10/31/2009, patient with c/o's nausea/vomiting, headaches, difficulty sleeping and backache. Tx: MS, Zofran Rx hme with medrol dose pak
Patient reported to RN a reaction to the second dose of Moderna COVID vaccine (LOT# 004M20A, exp. 07/10/2021) on 02/12/2021. Patient reported no allergic reaction with the first dose of Moderna COVID vaccine (LOT# 027L20A, exp. 06/30/2021). Patient reported hives on "abdomen, chest, and upper extremities" the morning after her vaccination. Patient reported no itchiness, swelling, and difficulty breathing. Patient contacted PCP and was prescribed a topical cream and steroid medication. Patient took medications for one week. Patient reported no known allergies, no chronic conditions, and no current medications. RN elevated situation to Clinical Supervisors. Clinical Supervisors elevated to medical consult team. Medical consult team approved patient for a Pfizer COVID vaccine booster dose. Patient reported she will return on 12/23/21 due to work schedule. On 12/23/2021, at approximately 0900, patient returned to facility. RN advised patient to wait for 30 minutes in observation and educated patient on signs/symptoms of when to alert observation staff. At 0924, patient received Pfizer COVID booster vaccine (LOT# FL3197, exp. 06/30/2022). At approximately 0939, RN  assessed patient. Patient denied rashes, itchiness, and difficulty breathing. At approximately 0954, RN reassessed patient. Patient denied rashes, itchiness, and difficulty breathing  RN educated patient on signs/symptoms of when to seek emergency care, to follow up with PCP, and to sign up on V-safe.
Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of Zostavax. Subsequently the patient experienced raised bump the size of a quarter after vaccination. Patient were advised to take non-steroidal anti-inflammatory drugs (NSAIDs) and apply ice to the site. The symptoms have occurred about a day or so after administration of the vaccine and dissipated a day later. No product quality complaint. This is one of several reports received from the same source. Additional information has been requested.
Fatigue and body aches, fever of 101.4 degrees Fahrenheit. Sick for a whole day so far.  It is clear to many people that the dosage for the 2nd dose of the Moderna shot is calibrated way too high for healthy people. I have received vaccines at various times throughout my life and never experienced side effects this strong. As of this writing I am still in the middle of these side effects.  Economist has been trying to suggest dialing down the dosage for young and healthy people. He is an influential economist and public policy advisor who persuaded the adoption their highly successful first-doses-first regiment for COVID-19 vaccines.   Note that stronger vaccine doses for the elderly and weaker vaccine doses for younger people has long been common for influenza vaccines. That seems like it would make great policy with the Moderna COVID-19 vaccine, as well as with others.  Vaccine hesitancy is understandably very high because the doses are calibrated too high for young and healthy people, resulting in strong side effects. This should be an easy problem to fix.
1. Fatigue lasting 3.5 weeks. It began the morning after vaccination and eventually went away on own weeks later. 2. Prolonged easy bruising. Large bloody bruises in the days and months following. The first had no known cause on upper right inner thigh, the other 2 bruises seemed much worse than what they should have been - both on lower left leg after minor hits from soccer ball and bike. 3. Menstrual cycle changes - I was very regular prior to vaccine. The first cycle during the vaccine was over 40 days. Following that first cycle, remaining cycles have been running short with very heavy bleeding (bleeding 6-7 days out of every 23-24). Ongoing for at least 6 months now.
edema over right eyebrow and along forehead, per caregiver's history.  Seen in emergency department given ventriculoperitoneal shunt, neurosurgery consulted, cranial ultrasound done, no neurosurgical issues found, discharged to home, swelling improved.
Large red, swollen patch (4 x 6")  at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Large red, swollen patch (4 x 6")  at the injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included Stent placement on 19-Mar-2019. Previously administered products included for Vitamin B12 deficiency: Vitamin B12 on 02-Dec-2020. Concurrent medical conditions included Allergy to vaccine (Tetanus toxoid), Milk allergy, Allergy to chemicals (Off insect spray (dry formula only)), Blood pressure high since 15-Mar-2019 and Vitamin B12 deficiency since 30-Nov-2020. Concomitant products included LOSARTAN from 19-Mar-2019 to an unknown date and METOPROLOL from 19-Mar-2019 to an unknown date for Blood pressure high, ACETYLSALICYLIC ACID (BABY ASPIRIN) from 19-Mar-2019 to an unknown date for an unknown indication.    On 30-Dec-2020 at 2:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jan-2021 at 9:00 AM, the patient experienced VACCINATION SITE ERYTHEMA (Large red, swollen patch (4 x 6")  at the injection site). On 25-Jan-2021, VACCINATION SITE ERYTHEMA (Large red, swollen patch (4 x 6")  at the injection site) had resolved.            Large, red swollen patch (4 x 6 inches) on left arm. It resolved over time, but the skin looked different in that area for awhile (kind of burnt looking). It eventually faded away. No treatment medication us was reported/Provided   This case was linked to MOD-2021-025544 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Follow-up received on 05-Apr-2021 included no new information. On 07-Apr-2021: Follow-up information indicated patient's prior vaccine, allergies, medical history, concomitant medications and  event resolved date were provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
EYE STRAIN; DEHYDRATION; FELT LETHARGIC A LITTLE BIT; DULL HEADACHE; This spontaneous report received from a patient concerned a 35 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21/JUN/2021) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced eye strain. On 05-APR-2021, the subject experienced dehydration. On 05-APR-2021, the subject experienced felt lethargic a little bit. On 05-APR-2021, the subject experienced dull headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from eye strain, dehydration, felt lethargic a little bit, and dull headache on APR-2021. This report was non-serious.
pt recvd vax & devel splotchy rash & numbness lt throat area w/in 10-15 mins p/vax
acute onset of transverse myelitis on 21AUG98 w/a sensory level @ T8, acute urinary retention & evolving paralysis of lower extremities;pt started on med & transferred to another hosp;
I had swelling and pain in my left arm near injection site, 12x15 cm of swelling, I went to Urgent care on the 8th they weren't sure but thought it was a staff infection and was prescribed antibiotics, i fully recovered
Pt reported significant arm pain resulting in loss of use in days following administration.  Pt. is currently under a doctor's care, undergoing physical therapy and has had an MRI.
A report was received from a health care professional on 12/2/03 concerning an unspecified number (approximately 5 to 6) vaccinees under 4 years of age who inadvertently received Fluvirin on unspecified dates. On unspecified dates, the vaccinees inadvertently received Fluvirin 0.5ml IM> The vaccinees did not experience any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/20/04: A follow up report was received from a health care professional concerning a 3 year old female vaccinee who inadvertently received Fluvirin on 11/17/03. On 11/17/03 the vaccinee inadvertently received Fluvirin. No adverse effects were reported at the time of reporting. No follow up pending. All information received.
Swollen lymph node in left arm; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 13May2021 at 15:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. The patient did not receive any other medications within two weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 22Apr2021 at 15:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 16:00, the patient experienced swollen lymph node in left arm (the arm where shot was administered). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. On an unknown date in 2021, the patient underwent nasal swab test and the result was negative. The clinical outcome of the event swollen lymph node in left arm was not recovered at the time of the report.   No follow-up attempts are needed. No further information is expected.
DEHYDRATED PER ER; FAST HEART RATE; ACHES; FEVER; This spontaneous report received from a patient concerned a 63 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A, and expiry:23/JUN/2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 07-APR-2021 02:00, the subject experienced aches. On 07-APR-2021 02:00, the subject experienced fever. On 07-APR-2021 04:00, the subject experienced fast heart rate. On an unspecified date, the subject experienced dehydration. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fast heart rate on 07-APR-2021, was recovering from fever, and aches, and the outcome of dehydration was not reported. This report was non-serious.
This spontaneous report as received from a Medical Assistant refers to a patient of an unknown age and gender. The patient's concurrent conditions, medical history, historical drugs and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored  VAQTA lot number N017094, expiration date 31-AUG-2018 (dose and route were not reported) for prophylaxis. No adverse effect was reported. Temperature: 9 grades Celsius to 25 grades Celsius "(10.1 C)" Time frame: 1 hour and 56 minutes. There was no previous temperature excursion involved. This is one of several reports received from the same source.; Sender's Comments:  US-009507513-1710USA003169: Original Case : 1710USA003115 US-009507513-1710USA003166: Original Case : 1710USA003115  US-009507513-1710USA003167: Original Case : 1710USA003115 US-009507513-1710USA003115: Original Case : 1710USA003115. US-009507513-1710USA003164: Original Case : 1710USA003115. US-009507513-1710USA003163: Original Case : 1710USA003115 US-009507513-1710USA003165: Original Case : 1710USA003115.
Breakthrough case admission after 3 vaccines  Pfizer 2/28/21 lot# En6201;  Pfizer 3/21/21 lot# EN6207;  Pfizer 12/15/21 lot# 33130BA;
Pt. was given only Hib diluent - powder vial was not reconstituted and not given. No adverse reactions noted. Pt. was revaccinated per CDC recommendation.
So roughly a week after my vaccine, I started having acid reflux and wheezing and a ringing in my left ear as well. I went to see an ENT and he prescribed a medication which was to help reduce swelling in my esophagus, I do not remember the dates or the medication name I am sorry, I am in the field right now not home. He also told me to refrain from chocolate, caffeine, carbonated drinks and those things. Doing that has helped with those. The ringing in my ear he addressed as well and I went to an audiologist and they told me I had Tinnitus. Since then I have been fitted for hearing aids and that has helped the Tinnitus a little bit.
Pt recvd Engerix-B & 10 days p/inject exp hives all over body x/face; tx w/Pred;